MADRID, 27 Feb. (EUROPA PRESS) –
The board of directors of Grifols has agreed to appoint Nacho Abia as the new CEO and as the new director through the co-option system, as reported by the blood products company to the National Securities Market Commission (CNMV).
Abia will temporarily appear in the category of other external directors, pending his becoming an executive director once he assumes the position of CEO with effect from April 1.
The next CEO of Grifols is a senior manager with 25 years of international management experience who has worked in listed companies in the life sciences and medical technology sectors.
Abia is part of the board of directors of AdvaMed (Advanced Medical Technology Association) in the United States, the board of directors of the United States-Spain Chamber of Commerce and is also a member of the board of trustees of the ‘Lehigh Valley Health Network’, a system hospital composed of 13 hospitals and multiple healthcare centers in Pennsylvania.
In the past, he served on the board of directors of Evident Corporation, a company in the field of life sciences and industrial solutions.
Abia’s appointment as director must be ratified at the next Grifols shareholder meeting.
On February 5, Grifols announced changes in its governance with the aim of separating management from the ownership of the company, in the hands of the Grifols family.
In addition to the election of Nacho Abia as CEO with effect from April 1, the company decided to maintain Thomas Glanzmann as executive president, while Raimon Grifols and Víctor Grifols Deu assume the position of proprietary directors and end their executive stage. , abandoning his functions as Chief Corporate Officer (CCO) and Chief Operating Officer (COO).
According to the company, these changes are part of a corporate governance strategy “planned and initiated in 2022”, promoted by Raimon Grifols and Víctor Grifols Deu together with the board of directors of the multinational, which suffered sharp falls on the stock market after the report of the Gotham firm.
